SK Hynix Develops Next-Generation Mobile NAND Solution ZUFS 4.0
Mass production of industry's best-performing product for on-device AI smartphones to begin in 3Q Performance degradation over time improved, while lifetime increased by 40% SK hynix to expand leader
USARAD, Nanox's Teleradiology Subsidiary, Awarded Accreditation From The Joint Commission
Company earns Gold Seal of Approval for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an in
Healthpeak Properties Has Acquired KSP's Minority Interest In The Joint Ventures In Eight Lab Buildings In Cambridge And Lexington, Massachusetts; No Financial Terms Disclosed
Healthpeak Properties, Inc. (NYSE:DOC) ("Healthpeak") and King Street Properties ("KSP") today announced that Healthpeak has acquired KSP's minority interest in the joint ventures in eight lab buildin
The Joint Corp. to Participate in Upcoming Investor Conferences
SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic network, announced that President and Chief
Joint Is Maintained at Buy by B. Riley Securities
Joint Is Maintained at Buy by B. Riley Securities
Express News | B. Riley Securities Maintains Buy on Joint, Raises Price Target to $20
Estimating The Fair Value Of The Joint Corp. (NASDAQ:JYNT)
Key Insights The projected fair value for Joint is US$18.18 based on 2 Stage Free Cash Flow to Equity With US$16.12 share price, Joint appears to be trading close to its estimated fair value The
Earnings Call Summary | The Joint(JYNT.US) Q1 2024 Earnings Conference
The following is a summary of the The Joint Corp. (JYNT) Q1 2024 Earnings Call Transcript:Financial Performance:The Joint Corp. reported Q1 2024 system-wide sales of $126.3 million, a 9% increase year
Is The Joint Corp. (NASDAQ:JYNT) Trading At A 48% Discount?
Joint First Quarter 2024 Earnings: EPS Beats Expectations
The Joint Corp (JYNT): Hold Rating Maintained Amidst Transition and Mixed Performance
Express News | Joint Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reiterated FY23 System-wide Sales Guidance. Also, Roth MKM Reiterated a Buy Rating on the Stock and Raised Its Price Target From $13 to $16
Express News | Roth MKM Reiterates Buy on Joint, Raises Price Target to $16
Joint Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 5.61% Roth MKM $13 → $16 Reiterates Buy → Buy 09/14/2023 -14.19% Roth MKM $16 → $13 Maintains B
Express News | The Joint Corp. : Craig-Hallum Raises Target Price to $10.5 From $8.75
The Joint Corp (JYNT) Q1 2024 Earnings: Revenue Grows, Surpassing Analyst Projections
Express News | The Joint Corp. Reiterated Guidance, 2024 System-Wide Sales Expected To Be $530M-$545M
Express News | Joint Corp: Sees 2024 System-Wide Sales to Be Between $530 Mln and $545 Mln Dollars
Earnings Flash (JYNT) THE JOINT Posts Q1 Revenue $29.7M, Vs. Street Est of $29.6M
04:33 PM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (JYNT) THE JOINT Posts Q1 Revenue $29.7M, vs. Street Est of $29.6M
Express News | Joint Q1 Adjusted Ebitda USD 3.5 Million
No Data